Tuesday, March 16, 2021

The French regulatory system facing the development of antitumor immunotherapy: Issues related to patient access to new therapies according to the French society of ImmunoTherapy against Cancer (FITC)

xlomafota13 shared this article with you from Inoreader

Bull Cancer. 2021 Mar 11:S0007-4551(21)00067-9. doi: 10.1016/j.bulcan.2020.12.008. Online ahead of print.

NO ABSTRACT

PMID:33715847 | DOI:10.1016/j.bulcan.2020.12.008

View on the web

No comments:

Post a Comment

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...